{
    "2018-02-23": [
        [
            {
                "time": "2018-01-02",
                "original_text": "A Look at Vanda Pharmaceuticals’ Product Portfolio",
                "features": {
                    "keywords": [
                        "Vanda Pharmaceuticals",
                        "Product Portfolio"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Endo, Glaxo to Settle Suits Over Testosterone Drug",
                "features": {
                    "keywords": [
                        "Endo",
                        "Glaxo",
                        "Settle",
                        "Suits",
                        "Testosterone Drug"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Analysts’ Post-4Q17 Recommendations for Eli Lilly",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommendations",
                        "Eli Lilly",
                        "4Q17"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Comparing Eli Lilly’s Post-4Q17 Valuation",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Valuation",
                        "4Q17"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Today’s Research Reports on Trending Tickers: InspireMD and Eli Lilly and Company",
                "features": {
                    "keywords": [
                        "Research Reports",
                        "Trending Tickers",
                        "InspireMD",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Eli Lilly’s Animal Health Segment Performed in 4Q17",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Animal Health",
                        "Segment",
                        "4Q17"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "animal health",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}